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     When discussing signs and symptoms of Chagas disease we look at the two phases 
the disease occurs in, acute and chronic.  In the acute phase of Chagas disease caused by 
T. cruzi symptoms are mild and often not seen.  Symptoms include fever, headache, 
enlarged lymph glands, difficulty breathing, chest pain, and abdominal pain.  Some 
individuals have a purple swelling to the lid of one eye, called Romaña sign, after the 
initial bite from the triatomine bug (Chagas disease, 2010).  In the chronic phase 
symptoms include gastrointestinal problems and cardiac symptoms.  The majority of 
individuals with chronic Chagas disease will present with cardiac symptoms as the 
disease process attacks cardiac muscle leading to heart failure (Chagas disease, 2010).   
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     Chagas disease is transmitted when the 
parasite T. cruzi enters the body.  This 
entry is done through the triatomine insect 
also known as the “kissing bug”, which 
hosts the parasite T. cruzi (CDC, 2014).  
The parasites main mode of transmission is 
through defecation of feces from the 
triatomine bug to its human host.  Being a 
vector borne disease, it can also be 
transmitted through food and drink infected 
by T. cruzi.  The disease may also be 
transmitted congenitally, through blood 
transfusions, or organ transplants 
(Montgomery, Starr, Canty, Edwards, & 
Meymandi, 2014).  In the human host the 
acute phase of T. cruzi is replicated in most 
nucleated cell types.  The T. cruzi will 
activate cell signaling pathways used 
during invasion of the human host cells.  
During the chronic phase of the disease, the 
T. cruzi parasite will primarily live in 
cardiac and smooth muscle cells.  T. cruzi 
can cause hypertrophy, inflammation, and 
fibrosis, in the cell, which can lead to heart 
failure and gastrointestinal disorders (Mott, 
Lenormand, Costales, Fredberg, & 
Burleigh, 2009). 
 
     It is important for healthcare professionals practicing in different levels to be aware 
of Chagas disease.  Awareness of the disease is important because of the number of 
infected individuals in the United States and the substantial knowledge deficit among 
physicians Chagas disease (Stampert and Montgomery, 2010).  Understanding at risk 
populations, immigrants from areas where Chagas disease is endemic, individuals who 
have traveled to those areas, and areas of poor sanitation here in the United States, can 
help the healthcare provider recognize Chagas disease and limit the diseases impact on 
patients.  In catching and treating the disease in the acute phase long term effects of 
chronic Chagas disease can be prevented.  Chagas disease has been responsible for 
30,000 to 45,000 prevalent cases of cardiomyopathy leading to heart failure (Custer et 
al, 2012).. 
     It is also important to recognize the risk posed to the population through donations 
of blood and solid organs.  Blood is now being tested for T. cruzi and the testing has 
been shown to be effective in recognizing the disease.  Each donor is tested a single 
time this process has been shown to decrease the risk of donor derived T. cruzi 
infection (Custer et al, 2012).  Individuals who test positive are referred to a physician 
for further evaluation and treatment as the test is not confirmatory for the disease 
(Custer et al, 2012).  The risk of transmission through organ transmission is low but 
does exist.  In a 2013 study it was shown that only 19 percent of US organ procurement 
organizations test for T. cruzi (Huprikar et al, 2013).  Understanding at risk individuals 
who are potential donors may help to increase the number of organs tested for T. cruzi.  
Individuals may still receive organs from donors infected with T. cruzi but need to be 
monitored closely for effects of Chagas disease (Huprikar et al, 2013). 
     The public needs to be made aware of diseases such as Chagas disease.  This is the 
responsibility of healthcare providers of all levels.  Individuals leaving the country and 
traveling to areas where Chagas disease is endemic need to be educated on signs and 
symptoms and methods of prevention.  If these individuals become infected by T. cruzi 
they will hopefully understand signs and symptoms and not let acute Chagas disease 
develop into the chronic form. 
 
     Parasitic infections are a common 
occurrence worldwide and are often more 
common in low income countries.  While 
these infections are associated with poor 
compromised communities outside the 
United States these diseases effect people 
within the United States and are more 
common than realized.  One specific 
parasitic infection infects its human host 
causing Chagas disease.  Chagas disease is 
an infection that occurs from the parasite T. 
cruzi and was named for the Brazilian 
physician Carlos Chagas who discovered 
the disease in 1909 (CDC, 2014).  
According to the Centers for Disease 
Control (CDC, 2014), Chagas disease has 
been targeted as a priority for public health 
action, and is considered one of the 
neglected parasitic infections.  The CDC 
(2014) considers Chagas disease a priority 
due to its severity, the number of people 
infected, and the ability to prevent and treat 
the disease.  According to Stampert and 
Montgomery (2010), there is a substantial 
knowledge deficit among physicians about 
Chagas disease.  This is concerning when 
one considers the harmful effects of the 
disease and the amount of people infected in 
the United States.  Chagas disease can be 
acquired in the United States as there have 
been cases of T. cruzi vector borne 
infections in Mississippi (Canty et. al., 
2012). 
     Currently there are more than 300,000 
individuals infected with Chagas disease in 
the United States (Woodhall, Jones, Cantey, 
Wilkins, & Montgomery, 2014).  The disease 
is an endemic across Central and South 
America, but the parasite that carries the 
illness has been found in the United States 
and there have been documented cases of 
vector-borne infection in the United States 
(Woodhall, et al., 2014).  The disease will 
persist for the life of the patient unless 
treatment is initiated.  If left alone the disease 
has potential life threatening effects including 
apical aneurysm, heart failure, megacolon, 
megaesophagus, and the risk of stroke is 
increased (Woodhall, et al., 2014).  The 
disease also carries potential congenital 
effects including hepatosplenomegaly, 
anemia, or thrombocytopenia.  Treatment is 
indicated for Chagis disease in patients 
younger than 18 and for most adults younger 
than 50 who do not have cardiomyopathy.   
Drugs used to treat Chagas disease are not 
approved by the Food and Drug 
Administration but are available through the 
CDC (Woodhall, et al., 2014). 
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Nursing Implications 
     Chagas disease represents a burden to the United States health system with over 
300,000 individuals being infected (Woodhall et al, 2014).  The disease presents 
severe complications if left untreated.  The CDC list Chagas disease as a priority for 
public health action (CDC, 2014).  The designation of being a priority for action 
implies that we as healthcare professionals need to understand and learn about the 
disease its processes and risk factors.  In doing this we can positively impact the lives 
of those infected with Chagas disease and prevent long term complications.  
Understanding diseases such as these are important as the world we live in becomes 
smaller.   
Case Study 
     A 53 year old female presents to the emergency department with complaints of left 
eye pain, headaches, daily fevers up to 102°F, dyspnea on exertion, decreased energy, 
decreased appetite, and a blotchy rash.  The patient had just recently returned from a 
three week stay in Costa Rica.  The patient stayed in a small village in Costa Rica that did 
not have netting to cover the windows and bed.  The patient did not have any symptoms 
until 2 days after her return to the United States.  Initially the patient was seen for left eye 
swelling and pain and was treated for conjunctivitis and an allergic reaction.  The patient 
did not respond to these treatments, which prompted a referral to the emergency 
department.  Upon physical exam at the emergency department the patient vital signs 
were all within normal limits, temperature 37.1°C, heart rate 91 beats/min, blood pressure 
98/62 mmHg, respiratory rate 18 breaths/min, and oxygen saturation 98% on room air. 
The patient was in no apparent distress. There was periorbital edema and mild erythema 
of the left eye without visible discharge.  The right eye was normal. All other physical 
examinations were unremarkable (Carter, Juliano, Montgomery, & Qvarnstrom, 2012).   
     Diagnostic test for the patient were done and results were as follows.  The patient 
had an abnormal 12-lead echocardiogram (EKG) revealing sinus rhythm with a low 
voltage QRS complex.  In response to the abnormal EKG a transthoracic 
echocardiogram (TTE) was performed.  The TTE showed normal left ventricular 
ejection fraction (60%), but noted diastolic left ventricular dysfunction, elevated left 
ventricular filling pressure, dilated left atrium, thickened pericardium, and a small 
circumferential pericardial effusion. Peripheral blood smear showed trypomastigotes of 
T. cruzi. This finding was confirmed by the CDC, Parasitic Diseases Branch.  All other 
lab values were unremarkable. (Carter, Juliano, Montgomery, & Qvarnstrom, 2012).  
The patient was treated for Chagas disease using CDC recommendations and the 
patient returned to normal function including the function of the left ventricle (Carter, 
Juliano, Montgomery, & Qvarnstrom, 2012).   
Above:  The triatomine, the vector for the T. cruzi parasite. Copyright 2014 by CDC 
 
Above:  Swelling of one eyelid called Romaña sign is a indicator of Acute Chagas 
disease  
Copyright 2014 by CDC 
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Left and Right:  The parasite T. 
Cruzi in peripheral blood smears 
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